Chapter 17 describes the effective strategic leadership of CEO Andrea Jung at Avon [http://www.avoncompany.com/]. In contrast, Bristol-Myers Squibb [http://www.bms.com/] CEO Peter Dolan is described as less effective. Access these two organizations' Web sites and then answer the following questions:

1. Based on the information available at its Web site, what is the nature of leadership in each firm? Consider leadership activities, processes, and styles.
   
   
2. Using your answer to Question 1, explain the approach to leadership that seems to most nearly fit each of the firms.
   
   

Internet Exercise
The opening incident in Chapter 17 discusses the troubled leadership of Richard Scrushy, CEO of HealthSouth. In 2003, after your text was completed, Scrushy lost his CEO position following an indictment from the U.S. Department of Justice. As of December 2003, however, he refused to step down as a member of the Board of Directors.

Under Scrushy's leadership, HealthSouth became a model of corporate irresponsibility. In fact, on HealthSouth's Web site today, under the financial statements section, there appears the following notice: "In light of recent investigations into HealthSouth's financial reporting and related activity, the financial statements currently found on this website should no longer be relied upon. Additional information will be provided as it becomes available." Visit HealthSouth's [http://www.healthsouth.com/] Web site and answer the following:

1. What style of leadership did Scrushy use in leading HealthSouth?
   
   
2. How did the lack of ethics at HealthSouth affect the interests of various groups of stakeholders (for example, consumers, investors, employees, and so on)?
   
   
3. In your opinion, what will it take to restore ethical leadership at HealthSouth?
   
   

Explore Further
Another healthcare giant, hospital management firm HCA, also has ethical problems. Some of its former top managers are currently under indictment for Medicaid fraud, and the firm paid a $750 million settlement to the federal government. In 2002, HCA brought in a new CEO, Jack O. Bovender, Jr., to help address ethical and operational problems at HCA. Access HCA's [http://www.hcahealthcare.com/] Web site, then view the "Investor Relations" page. Another good site is BusinessWeek's online interview with Bovender. In your opinion, is Bovender's leadership likely to help HCA improve its performance and its image? Why or why not?